Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)

SHA:600436 Revenue

Zhangzhou Pientzehuang Pharmaceutical had revenue of 1.83B CNY in the quarter ending June 30, 2026, a decrease of -18.12%. This brings the company's total for the last twelve months to 8.20B, down -22.06% year-over-year. In the year 2025, Zhangzhou Pientzehuang Pharmaceutical had annual revenue of 9.00B, down -16.56%. That makes Zhangzhou Pientzehuang Pharmaceutical the 6,755th largest company in the world by revenue and 955th in China.

• Revenue (ttm): 8.20B
• Revenue Growth: -22.06%
• P/S Ratio: 9.37
• Revenue / Employee: 2.84M
• Employees: 2,886
• Market Cap: 77.33B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Distribution Industry 5.09B 48.9%
• Pharmaceutical Manufacturing 4.42B 42.4%
• Cosmetics Manufacturing 660.09M 6.3%
• Other 243.99M 2.3%

By Geography

Chart

• China 8.59B 95.4%
• Overseas 415.06M 4.6%

Fiscal year ended Dec 31, 2025 See the full SHA:600436 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.00B	-1.79B	-16.56%
Dec 31, 2024	10.79B	729.37M	7.25%
Dec 31, 2023	10.06B	1.36B	15.69%
Dec 31, 2022	8.69B	672.45M	8.38%
Dec 31, 2021	8.02B	1.51B	23.20%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error